Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
Max Hodak, the former president and co-founder of Neuralink, detailed onstage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
Contenu original affiche; la traduction localisee n'est pas encore disponible.
Ce qui s'est passé
Max Hodak, the former president and co-founder of Neuralink, detailed onstage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
Pourquoi c'est important
The development may change operating conditions or market expectations around AI. Further confirmation and measurable outcomes matter.
Entités concernées
Voir les preuves
1 articles · 1 publication d'origine · 1 independantes
- TechCrunch AISource primaire · Confirme · EN · 100%Science Corporation implants its vision-restoring chip in its first Stargardt disease patient ↗
Affirmations
- Science Corporation implants its vision-restoring chip in its first Stargardt disease patient Observé
Divergences
Aucune divergence importante détectée dans les preuves disponibles.
Chronologie
- Premier signalement
Mouvement de marché suivant l'événement
La réaction du marché n'est pas encore disponible pour cet actif et cette fenêtre.